Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 1 | 595 | 559 | 0.0065 | 0.0058 | 0.9395 | 0.9416 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 2 | 561 | 526 | 0.0063 | 0.0058 | 0.9376 | 0.9416 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 3 | 477 | 452 | 0.0045 | 0.0058 | 0.9476 | 0.9416 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 1 | 1042 | 801 | 0.0435 | 0.0334 | 0.7687 | 0.8371 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 2 | 1199 | 1034 | 0.0298 | 0.0334 | 0.8624 | 0.8371 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 3 | 1251 | 1101 | 0.0271 | 0.0334 | 0.8801 | 0.8371 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 1 | 712 | 628 | 0.0151 | 0.0125 | 0.8820 | 0.9029 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 2 | 639 | 572 | 0.0121 | 0.0125 | 0.8951 | 0.9029 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 3 | 833 | 776 | 0.0103 | 0.0125 | 0.9316 | 0.9029 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 1 | 1199 | 1142 | 0.0103 | 0.0092 | 0.9525 | 0.9423 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 2 | 832 | 777 | 0.0099 | 0.0092 | 0.9339 | 0.9423 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 3 | 688 | 647 | 0.0074 | 0.0092 | 0.9404 | 0.9423 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 1 | 486 | 455 | 0.0056 | 0.0041 | 0.9362 | 0.9488 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 2 | 424 | 402 | 0.0040 | 0.0041 | 0.9481 | 0.9488 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 3 | 422 | 406 | 0.0029 | 0.0041 | 0.9621 | 0.9488 |
COLO 858 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 7209 | 989 | 1.0536 | 1.0000 | 0.1372 | 0.1369 |
COLO 858 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 6958 | 942 | 1.0191 | 1.0000 | 0.1354 | 0.1369 |
COLO 858 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 6352 | 878 | 0.9273 | 1.0000 | 0.1382 | 0.1369 |
COLO 858 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 5195 | 826 | 0.7401 | 0.8239 | 0.1590 | 0.1662 |
COLO 858 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 5368 | 976 | 0.7440 | 0.8239 | 0.1818 | 0.1662 |
COLO 858 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 6922 | 1092 | 0.9876 | 0.8239 | 0.1578 | 0.1662 |
COLO 858 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 3740 | 546 | 0.5411 | 0.5771 | 0.1460 | 0.1387 |
COLO 858 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 3833 | 559 | 0.5546 | 0.5771 | 0.1458 | 0.1387 |
COLO 858 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 4284 | 532 | 0.6356 | 0.5771 | 0.1242 | 0.1387 |
COLO 858 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 3899 | 757 | 0.5322 | 0.4762 | 0.1942 | 0.1912 |